1831 related articles for article (PubMed ID: 26987352)
1. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
2. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
4. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
[TBL] [Abstract][Full Text] [Related]
6. Stem cell applications in diabetes.
Noguchi H
J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
[TBL] [Abstract][Full Text] [Related]
7. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
[TBL] [Abstract][Full Text] [Related]
8. The Human Endocrine Pancreas: New Insights on Replacement and Regeneration.
Domínguez-Bendala J; Lanzoni G; Klein D; Álvarez-Cubela S; Pastori RL
Trends Endocrinol Metab; 2016 Mar; 27(3):153-162. PubMed ID: 26774512
[TBL] [Abstract][Full Text] [Related]
9. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
[TBL] [Abstract][Full Text] [Related]
10. SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism.
Lithovius V; Saarimäki-Vire J; Balboa D; Ibrahim H; Montaser H; Barsby T; Otonkoski T
Diabetologia; 2021 Mar; 64(3):630-640. PubMed ID: 33404684
[TBL] [Abstract][Full Text] [Related]
11. Cell differentiation: therapeutical challenges in diabetes.
Roche E; Vicente-Salar N; Arribas M; Paredes B
J Stem Cells; 2012; 7(4):211-28. PubMed ID: 24196797
[TBL] [Abstract][Full Text] [Related]
12. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
[TBL] [Abstract][Full Text] [Related]
13. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
[TBL] [Abstract][Full Text] [Related]
14. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes.
Matsumura W; Fujita Y; Nakayama C; Shinkuma S; Suzuki S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Mar; 89(3):263-271. PubMed ID: 29229433
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
Quiskamp N; Bruin JE; Kieffer TJ
Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
[TBL] [Abstract][Full Text] [Related]
16. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
Dadheech N; James Shapiro AM
Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
[TBL] [Abstract][Full Text] [Related]
17. Pluripotent stem cell replacement approaches to treat type 1 diabetes.
Pellegrini S; Piemonti L; Sordi V
Curr Opin Pharmacol; 2018 Dec; 43():20-26. PubMed ID: 30071348
[TBL] [Abstract][Full Text] [Related]
18. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
[TBL] [Abstract][Full Text] [Related]
19. Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette.
Fan Y; Luo Y; Chen X; Li Q; Sun X
J Reprod Dev; 2012; 58(4):404-9. PubMed ID: 22498813
[TBL] [Abstract][Full Text] [Related]
20. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]